BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 11867732)

  • 1. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity.
    Schmidt D; Müller S
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2872-7. PubMed ID: 11867732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.
    Kotaja N; Karvonen U; Jänne OA; Palvimo JJ
    Mol Cell Biol; 2002 Jul; 22(14):5222-34. PubMed ID: 12077349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation.
    Depaux A; Regnier-Ricard F; Germani A; Varin-Blank N
    Oncogene; 2007 Oct; 26(46):6665-76. PubMed ID: 17533377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of PIAS1 in the sumoylation of tumor suppressor p53.
    Kahyo T; Nishida T; Yasuda H
    Mol Cell; 2001 Sep; 8(3):713-8. PubMed ID: 11583632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activity of peroxisome proliferator-activated receptor gamma is modulated by SUMO-1 modification.
    Ohshima T; Koga H; Shimotohno K
    J Biol Chem; 2004 Jul; 279(28):29551-7. PubMed ID: 15123625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
    Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
    J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of yeast PIAS-type SUMO ligases in vivo and in vitro.
    Takahashi Y; Toh-E A; Kikuchi Y
    J Biochem; 2003 Apr; 133(4):415-22. PubMed ID: 12761287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription.
    Nishida T; Yasuda H
    J Biol Chem; 2002 Nov; 277(44):41311-7. PubMed ID: 12177000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
    Buschmann T; Lerner D; Lee CG; Ronai Z
    J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a substrate recognition site on Ubc9.
    Lin D; Tatham MH; Yu B; Kim S; Hay RT; Chen Y
    J Biol Chem; 2002 Jun; 277(24):21740-8. PubMed ID: 11877416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
    Lin JY; Ohshima T; Shimotohno K
    FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SUMO-1 modification activates the transcriptional response of p53.
    Rodriguez MS; Desterro JM; Lain S; Midgley CA; Lane DP; Hay RT
    EMBO J; 1999 Nov; 18(22):6455-61. PubMed ID: 10562557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role for SUMO modification in facilitating transcriptional repression by BKLF.
    Perdomo J; Verger A; Turner J; Crossley M
    Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
    Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
    Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIAS proteins promote SUMO-1 conjugation to STAT1.
    Ungureanu D; Vanhatupa S; Kotaja N; Yang J; Aittomaki S; Jänne OA; Palvimo JJ; Silvennoinen O
    Blood; 2003 Nov; 102(9):3311-3. PubMed ID: 12855578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamin interacts with members of the sumoylation machinery.
    Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
    J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of de novo DNA methyltransferase 3a (Dnmt3a) by SUMO-1 modulates its interaction with histone deacetylases (HDACs) and its capacity to repress transcription.
    Ling Y; Sankpal UT; Robertson AK; McNally JG; Karpova T; Robertson KD
    Nucleic Acids Res; 2004; 32(2):598-610. PubMed ID: 14752048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO modification of STAT1 and its role in PIAS-mediated inhibition of gene activation.
    Rogers RS; Horvath CM; Matunis MJ
    J Biol Chem; 2003 Aug; 278(32):30091-7. PubMed ID: 12764129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression and coactivation of CCAAT/enhancer-binding protein epsilon by sumoylation and protein inhibitor of activated STATx proteins.
    Kim J; Sharma S; Li Y; Cobos E; Palvimo JJ; Williams SC
    J Biol Chem; 2005 Apr; 280(13):12246-54. PubMed ID: 15661739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.